Copper intrauterine device vs. depot medroxyprogesterone acetate for contraception
Guirguis-Blake, J.
American Family Physician 83(1): 35-36
2011
ISSN/ISBN: 0002-838X PMID: 21888124 Document Number: 222107
Document emailed within 1 workday
Related Documents
Haddad, L.B.; Cwiak, C.; Jamieson, D.J.; Feldacker, C.; Tweya, H.; Hosseinipour, M.; Hoffman, I.; Bryant, A.G.; Stuart, G.S.; Noah, I.; Mulundila, L.; Samala, B.; Mayne, P.; Phiri, S. 2013: Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate Contraception 88(6): 737-743Steinauer, J.E.; Upadhyay, U.D.; Sokoloff, A.; Harper, C.C.; Diedrich, J.T.; Drey, E.A. 2015: Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion Contraception 92(6): 553-559
Krashin, J.W.; Stuart, G.S.; Garrett, J.; Spector, H.; Bryant, A.G.; Charm, S.; Morse, J.E. 2017: Contraception Insurance Coverage and Receipt of Long-Acting Reversible Contraception or Depot Medroxyprogesterone Acetate on the Day of Abortion Obstetrics and gynecology 130(1): 109-117
Mishell, D.R. 1996: Pharmacokinetics of depot medroxyprogesterone acetate contraception Journal of Reproductive Medicine 41(5 Suppl): 381-390
Frederiksen, M.C. 1996: Depot medroxyprogesterone acetate contraception in women with medical problems Journal of Reproductive Medicine 41(5 Suppl): 414-418
Kaunitz, A.M. 1994: Long-acting injectable contraception with depot medroxyprogesterone acetate American Journal of Obstetrics and Gynecology 170(5 Pt 2): 1543-1549
Prabhakaran, S.; Sweet, A. 2012: Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability Contraception 85(5): 453-457
Kaunitz, A.M. 1996: Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer Journal of Reproductive Medicine 41(5 Suppl): 419-427
Zia, Y.; Tang, J.H.; Chinula, L.; Tegha, G.; Stanczyk, F.Z.; Kourtis, A.P. 2019: Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi Contraception 100(5): 402-405
Heffron, R.; Mugo, N.; Were, E.; Kiarie, J.; Bukusi, E.A.; Mujugira, A.; Frenkel, L.M.; Donnell, D.; Ronald, A.; Celum, C.; Baeten, J.M.; Celum, C.; Baeten, J.M.; Donnell, D.; Coombs, R.W.; Frenkel, L.M.; Hendrix, C.W.; Lingappa, J.; McElrath, M..Juliana.; Fife, K.; Were, E.; Tumwesigye, E.; Katabira, E.; Katabira, E.; Bukusi, E.; Cohen, C.; Wangisi, J.; Campbell, J.; Tappero, J.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Mugo, N.Rwamba.; Campbell, J.; Tappero, J.; Wangisi, J. 2014: Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception Aids 28(18): 2771-2776
Wanyonyi, S.Z.; Stones, W.R.; Sequeira, E. 2011: Health-related quality of life changes among users of depot medroxyprogesterone acetate for contraception Contraception 84(5): E17-E22
Cundy, T.; Cornish, J.; Roberts, H.; Reid, I.R. 2002: Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception American Journal of Obstetrics and Gynecology 186(5): 978-983
Overton, E.Turner.; Shacham, E.; Singhatiraj, E.; Nurutdinova, D. 2008: Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception Contraception 78(2): 125-130
Knuth, U.A.; Yeung, C.H.; Nieschlag, E. 1989: Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception Fertility and Sterility 51(6): 1011-1018
Zipper, J.A.; Tatum, H.J.; Medel, M.; Pastene, L.; Rivera, M. 1971: Contraception through the use of intrauterine metals. I. Copper as an adjunct to the "T" device. the endouterine copper "T" American Journal of Obstetrics and Gynecology 109(5): 771-774
Lech, M.M. 2003: Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland Wiadomosci Lekarskie 56(7-8): 362-368
Beksinska, M.E.; Smit, J.A.; Kleinschmidt, I.; Farley, T.M.M. 2011: Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception South African Medical Journal 101(2): 131-135
Lech, M.M. 2003: Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland Wiadomosci Lekarskie 56(7-8): 362-368
Lech, M.M. 2003: Depot medroxyprogesterone acetate (DMPA) injectable contraception--safe, effective but neglected method of family planning in Poland Wiadomosci Lekarskie 56(7-8): 362-368
Bilgehan, F.; Dilbaz, B.; Karadag, B.; Deveci, C.D. 2015: Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception Journal of Obstetrics and Gynaecology Research 41(9): 1426-1432